Studies have demonstrated that elevated FATP2 expression in polymorphonuclear myeloid-derived suppressor cells leads to higher lipid accumulation in various patients with cancer than in healthy individuals, and that its inhibitors can reduce lipid entry into these cells indicating a role in immune regulation and potential antitumor effects 42. This evidence concerns the gene SLC27A2 and cancer.